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ABSTRACT
Background/aims Neurodegeneration with brain 
iron accumulation (NBIA) type I is a rare disease that 
can be divided into a classical or atypical variant, 
according to age of onset and clinical pattern. Neuro-
ophthalmological involvement has been documented in 
the classical variant but only anecdotically in the atypical 
variant. We sought to describe the visual and ocular 
motor function in patients with atypical form of NBIA 
type I.
Methods Cross-sectional study, including patients 
with genetically confirmed NBIA type I and classified 
as atypical variant, who underwent ophthalmological 
examination with best corrected visual acuity 
(BCVA), optical coherence tomography (OCT), fundus 
autofluorescence (FAF), electroretinography (ERG), visual 
evoked potentials (VEP) and video-oculography.
Results Seven patients with a mean BCVA of 
0.12±0.14 logMAR were included. Only two patients 
showed structural evidence of advanced retinopathy in 
OCT and FAF, and there were no cases of optic atrophy. 
ERG data, however, showed abnormal scotopic and/or 
photopic responses in all patients. VEP were normal in 
all three patients. Ocular fixation was markedly unstable 
(eg, increased rate of saccadic pulses) in the majority of 
patients (5). Additional mild ocular motor disturbances 
included low gain pursuit (2), hypermetric saccades 
(1), low gain optokinetic (2) and caloric and rotatory 
responses (3).
Conclusion Functional retinal changes associated with 
marked instability of ocular fixation should be included in 
the clinical spectrum of NBIA, particularly in the atypical 
form.
INTRODUCTION
Neurodegeneration with brain iron accumulation 
(NBIA) refers to a group of rare heterogeneous 
neurodegenerative disorders characterised by 
progressive and severe neurological impairment 
and excessive iron deposition in the basal ganglia.1–3
One of the core syndromes is associated with a 
recessive mutation in the pantothenate kinase-as-
sociated neurodegeneration (PKAN) gene, which 
accounts for approximately half the cases of NBIA, 
classified as type I.1 2 NBIA type I can be divided 
into two major subtypes according to age of onset 
and clinical progression: the classical variant that 
occurs early in the first decade of life, with predom-
inant extrapyramidal features and rapid clinical 
progression; and the atypical variant, which begins 
in the second or later decades, and extrapyramidal 
features are generally less severe and more slowly 
progressive.2–4
Neuro-ophthalmological involvement has been 
described in NBIA type I.1 2 5 Retinal degeneration 
seems to be the most consistent finding in clas-
sical variant (26%,6 68%2 and 20%4 in the three 
most representative series). Optic neuropathy has 
been also documented in the classical variant,4 6 
although Hayflick et al2 considered it to be infre-
quent (3%). In 2005, Egan et al5 analysed the 
electroretinographic features in 16 patients with 
genetically confirmed PKAN, although no clear 
distinction was made between classical and atypical 
variants. While a pigmentary retinopathy was docu-
mented in only 4 out 10 patients, in around 70% 
of patients, there was an abnormal electroretinog-
raphy (ERG).5 In atypical NBIA, visual function 
has been anecdotally reported, but retinopathy and 
optic atrophy seem to be rare.2
Oculomotor abnormalities in classical NBIA, 
suggestive of predominant midbrain degeneration, 
have been reported3 5 7 including slow vertical 
saccades, frequent square wave jerks, abnormal 
vertical optokinetic responses and an inability 
to suppress the vestibulo-ocular reflex (VOR).5 
Importantly, detailed ocular motor assessment using 
video-oculography and video-head impulse test in 
the atypical form has not been performed to date.
In our study, we provide a detailed visual and 
ocular motor analysis in patients with the atypical 
form of NBIA type I.
MATERIALS AND METHODS
Cross-sectional study including patients with genet-
ically confirmed (ie, mutation in PKAN) NBIA from 
our Neurogenetics Clinic, with a clinical phenotype 
consistent with atypical variant. Patients classified 
as NBIA classic variant,1 2 and those with advanced 
disease unable to cooperate were excluded.
Informed consent was obtained from all partic-
ipants, and ethics committee approved the study 
protocol.
All patients underwent the following clinical 
assessment:
Visual assessment
An ophthalmological evaluation was performed 
including best corrected distance visual acuity 
(BCVA; Snellen chart), slit lamp examination and 
dilated fundus exam.
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Additional assessment comprised: (1) colour fundus photog-
raphy (CFP; Topcon TRC-50EX; Topcon, Tokyo, Japan); mydri-
atic colour fundus digital photographs were taken centred on the 
fovea, with a 30° field of view; (2) spectral domain optical coher-
ence tomography (SD-OCT; Spectralis HRA-OCT, Heidelberg 
Engineering, Heidelberg, Germany); this was performed using 
evenly spaced lines scan pattern and the following parameters: 
870 nm acquisition speed, 35 000 A-scans per seconds, scan depth: 
1.8 mm and digital depth resolution: approximately 3.5 µm per 
pixel; (3) fundus autofluorescence (FAF) was obtained using a 
confocal blue laser autofluorescence system (488 nm) (Heidel-
berg Engineering, Heidelberg, Germany); after positioning the 
patient on the camera with the eye aligned for uniform illumina-
tion of the retina, the eye was bleached for 30 s with blue light, 
and a minimum of 10 frames of images were taken for aver-
aging to get the best possible image; (4) ERG was recorded using 
RETIscan (Roland Consult, Germany) with DTL-Plus electrodes 
and with the patients’ pupils fully dilated; multifocal ERG was 
performed according to published methods8; full-field ERG was 
recorded using a Ganzfeld Q450 stimulator according to ISCEV 
standards9; dark-adapted responses were obtained after 20 min 
of dark adaption and light-adapted responses after 10 min of 
light exposure (30 cd.s/m2) in the dome; (5) visual evoked poten-
tials (VEP) were carried out using Nicolet Viking Select software 
according to the current guidelines for pattern reversal VEP 
from the American Clinical Neurophysiology Society10; full-field 
stimulation was performed monocularly, using a high-contrast 
(>50%) black-and-white checkerboard pattern, at a reversal rate 
of 4/s.
Ocular motor assessment
All patients performed binocular video-oculography (VOG; 
VO425 Firewire Interacoustics; 105 Hz). After 5-point calibra-
tion, VOG assessment included ocular fixation (30 s) in dark 
and light, 20° gaze testing, 20° sinusoidal pursuit (10°/s, starting 
velocity), 10–30° saccades and 20°/s optokinetic nystagmus 
(OKN) both in the horizontal and vertical planes, right, left 
and head straight supine and head hanging positional testing 
in dark, and head-shaking-induced nystagmus test (HST) and 
mastoid vibration-induced nystagmus test (MVT). For smooth 
pursuit, the mean gain was calculated comparing target and 
eyes velocities.11 By definition a primary saccade was the first 
saccade within 100–500 ms after a target step. The time delay 
between target step and the start of primary saccades was taken 
as latency.11 12 Mean velocity was calculated for each primary 
saccade.11 12 Saccade amplitude was calculated, and the ratio 
between step and saccade amplitude was taken as the saccade 
accuracy.11 OKN gain was calculated by comparing eye mean 
velocity and stimulus (stripes or rotation) velocity. HST and 
MVT were considered positive when stimulation produced a 
reproducible, sustained nystagmus, with a slow-phase velocity 
(SPV) higher than 2° per second. VOR function was further 
assessed using monocular video-horizontal head impulse 
test (VHIT; EyeSeeCam Interacoustics; 220 Hz) and caloric 
and rotatory chair tests (Type Med 4 Synapsis). VHIT was 
performed with the patient in a seated position in room light. 
After a successful 5-point calibration, the patient kept fixating 
a target at ~1.5 m, while about 20 unpredictable head impulses 
to each side (right and left) were applied by the experimenter. 
VOR gain was calculated as the ratio of eye to head velocity at 
60 ms.13 Caloric tests were performed by irrigating the ears for 
25 s alternately with 50 mL of cold (30°C) and hot (44°C) water 
with a 5 min interval between ears. The induced nystagmus 
was recorded monocularly with VOG until it had completely 
decayed. Asymmetry of vestibular function was calculated using 
the Jongkees’ formula, and caloric paresis was defined by the 
response difference of ≥25% between the ears. For rotatory 
chair testing, the patients were seated in a chair in total dark-
ness, while sinusoidal cycles at specific frequencies (0.16 Hz, 
0.32 Hz and 0.64 Hz) were performed.
RESULTS
Seven patients with disease onset between 14 and 23 years old 
were included. Four patients were female. The median age was 
37 years and median disease duration was 16 years. Patients 
were genetically heterogeneous, with PKAN mutation 1070 
G>C transition being the most prevalent (n=5). Demographic 
and clinical data are presented in table 1.
Table 1 Demographic and clinical data
Patient 
number Gender Age (years)
Age at disease onset 
(years)
Disease duration 
(years) Type of mutation Neurological findings
1 F 23 14 9 c.1070G>C(p.Arg357Pro) 
c.1561G>A(p.Gly521Arg)
Oromandibular dystonia, postural 
instability and gait abnormalities.
2 F 37 20 17 c.1070G>C(p.Arg357Pro) Oromandibular dystonia, 
parkinsonism and cognitive 
decline.
3 M 19 16 3 c.1070G>C(p.Arg357Pro) Arm dystonia, postural 
instability and gait abnormalities.
4 F 48 23 25 c.1070G>C(p.Arg357Pro) Cognitive decline, speech 
abnormalities (palilalia) and 
parkinsonism.
5 M 49 22 27 c.1070G>C(p.Arg357Pro) 
c.1211A>T(p.Asn404lle)
Neuropsychiatric manifestations, 
oromandibular dystonia and gait 
abnormalities.
6 M 38 22 16 c.1583C>T(p.Thr528Met) Marked blepharospasm, cognitive 
decline and gait abnormalities.
7 F 36 20 16 c.1583C>T(p.Thr528Met) Marked blepharospasm, 
oromandibular dystonia and 
cognitive decline.
F, female; M, male.
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Visual findings
The mean BCVA was 0.12±0.14 logMAR, which corresponds 
to an approximate Snellen visual acuity of 20/25 (n=14 eyes). 
In all patients, the media were transparent, and fundus and 
CFP appearance was normal apart from evidencing mild retinal 
pigment epithelium mottling outside the posterior pole in 
four patients. There were no subjects demonstrating optic disc 
pallor, pigment retinal changes or vascular attenuation. In spite 
of a normal-appearing fundus, two patients (patients 1 and 3) 
presented with severe bilateral signs of retinopathy in structural 
exams. Specifically, SD-OCT showed disruption and disappear-
ance of the ellipsoid zone and external limiting membrane, and 
thinning of the outer nuclear layer (ONL) outside the central 
macula, with foveal architecture preserved in both cases. Addi-
tionally, FAF revealed a corresponding parafoveal ring of hyper-
autofluorescence, representing retinal metabolic dysfunction 
surrounding a normal hypoautofluorescent foveal area (figure 1). 
Importantly, visual acuity in these patients was 20/32 and 20/20. 
In another three patients (patients 2, 4 and 5), SD-OCT revealed 
mild thinning of the ONL in both eyes, showing no changes in 
the external layers. In these subjects, FAF appearance was normal 
(figure 1). Patient 6 had normal OCT and FAF examination, and 
for patient 7, OCT and FAF could not be performed due to poor 
cooperation.
The scotopic responses were abolished or residual in four 
patients (patients 1, 3, 4 and 6), while photopic responses were 
reduced or residual in all except patient 7. The flicker response 
was reduced and delayed in the majority of the patients, except 
for patients 6 and 7. Multifocal ERG revealed mainly focal 
responses with globally altered morphology but preservation of 
the central response in the entire group. Relevant ERG findings 
in our sample are shown in figure 1. VEP could not be performed 
Figure 1 Patient 1 with 20/20 vision in the LE. (A) CFP shows mottling of the RPE, but no pigmentary changes suggestive of pigmentary 
retinopathy. (B) FAF shows a well demarcated hyperautofluorescent ring surrounding the fovea and the optic disc, with abnormal 
hypoautofluorescence in the periphery. (C) SD-OCT demonstrates thinning of the outer nuclear layer (yellow asterisks), and disruption and 
disappearance of the more external retinal layers (white arrows) outside the central macula. Patient 2 with 20/20 vision in LE. (E) CFP shows only 
discrete mottling of the RPE. (F) FAF is normal. (G) SD-OCT demonstrates thinning of the outer nuclear layer (yellow asterisks), with preservation of 
the external retinal layers. ERG of patients 1 (D) and 2 (H), showing severe compromise of the rod and cone function. CFP, colour fundus photography; 
ERG, electroretinography; FAF, fundus autofluorescence; LE, left eye; RPE, retinal pigment epithelium; SD-OCT, spectral domain optical coherence 
tomography.
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in the majority of patients due to involuntary lid and head move-
ments. In patients 2, 3 and 5, P100 wave latency and amplitude 
was normal.
Patients’ visual assessment results are listed in table 2.
Ocular motor findings
Detailed ocular motor analysis was available in seven patients. 
Frequent saccadic intrusions interrupting ocular fixation were 
frequent in our sample and included pervasive single saccadic 
pulses in three patients (patients 1, 3 and 6) and continuous 
square wave jerks (SWJ) in three patients (patients 1, 2 and 5) 
(figure 2 and video - supplementary data). Patient 4 showed left 
beating nystagmus (SPV: 2.2°/seg) only in dark. Mean smooth 
pursuit gain was uniformly low (<0.8) in only two patients 
(patients 6 and 7). Saccade velocity (vertical and horizontal) was 
normal in the entire sample, ranging between 333 and 633°/s. 
Saccades overshooting the target (hypermetric) were observed in 
patient 3. OKN responses were slightly reduced in two patients 
(patients 2 and 6). Positional nystagmus in dark was detected in 
two patients (patients 4 and 6). HST was normal in all patients 
tested. MVT, however, induced horizontal nystagmus in four 
patients (patients 1, 2, 4 and 6). Positional testing, HST and 
MVT were not performed in patient 7 due to severe motor 
restriction. VOR evaluation showed essentially normal VHIT 
responses (range 0.83–1.20), mild hyporesponsiveness under 
rotatory stimulation in two patients (patients 3 and 6) and 
caloric hyporesponsiveness in two patients (patient 5 and 6).
Ocular motor data are listed in table 3.
DISCUSSION
Our results showed that in spite of a normal visual acuity and 
almost normal fundus appearance, all patients with atypical 
NBIA evidenced some degree of retinal dysfunction, with two 
patients additionally showing a clear structural retinopathy. 
Importantly, marked fixation instability (ie, saccadic pulses and 
square wave jerks) was detected in the majority of patients.
All our patients showed abnormal ERG responses, indicating 
both cone and rod widespread dysfunction. Of these, only 
two patients showed clear morphological changes in OCT and 
FAF, suggesting more advanced cone–rod retinal degeneration. 
Table 2 Visual findings
Patient 
number
BCVA Fundus 
examination* SD-OCT FAF ERG/ mfERG VEPRE LE
1 20/25 20/20 Discrete RPE 
mottling
-Loss of the ELM and 
photoreceptors’ IS and OS
-Profound ONL thinning 
outside the fovea
Parafoveal 
hyperautofluorescent 
ring
ERG full-field: Abolished SR, CR and OP. Residual PR. 
‘Flicker’ reduced and delayed.
mfERG: Globally altered morphology. Preservation 
of central response (ring 1) on both eyes, for both 
morphology and amplitude.
–
2 20/20 20/20 Discrete RPE 
mottling
Mild thinning of the ONL Normal ERG full-field: Normal SR. Reduced CR, PR and ‘flicker’ 
(asymmetry with lower amplitude in the RE). Residual OP.
mfERG: Some responses with altered morphology. Central 
response preserved bilaterally
Normal
3 20/20 20/20 Discrete RPE 
mottling
Loss of the ELM and 
photoreceptors’ IS and OS
-Profound ONL thinning 
outside the fovea
Parafoveal 
hyperautofluorescent 
ring
ERG full-field: Abolished SR and CR on LE and residual 
on RE. Abolished OP. Reduced PR. Reduced and delayed 
‘flicker’ response.
mfERG: Focal responses with globally altered morphology. 
Preservation of central response (ring 1), with better 
range in LE.
Normal
4 20/10 20/25 Normal Mild thinning of the ONL Normal ERG full-field: Abolished SR and OP. Residual PR and CR 
(mainly LE). ‘Flicker’ response reduced and delayed.
mfERG: Focal responses with globally altered morphology. 
Preservation of central response (ring 1), particularly in 
the LE.
–
5 20/50 20/40 Normal Mild thinning of the ONL Normal ERG full-field: Normal SR, CR and OP. PR and ‘flicker’ with 
amplitudes below the lower threshold of normality.
mfERG: Some locations within the central 30° core with 
reduced amplitude and morphology changes (especially 
in the pericentral rings 2 and 3) in both eyes. Central 
response preserved, although asymmetric (lesser extent 
in RE).
Normal
6 20/40 20/25 Discrete RPE 
mottling
Normal Ring-shaped increased 
autofluorescence in the 
hypoautofluorescent 
central macula.
ERG full-field: Abolished SR. CR with normal amplitudes 
but with delayed in RE. Residual potentials on LE and 
abolished on RE. PR severely reduced. Normal ‘flicker’ 
response.
mfERG: Focal responses with globally altered morphology, 
and preservation of central response (ring 1), particularly 
in the LE.
–
7 20/25 20/25 Normal – – ERG full-field: Responses within normal limits.
mfERG: Pericentral responses (rings 2 and 3) showing 
focal alterations, particularly in response amplitude.
Central response preserved.
–
*Fundus examination included colour fundus photography.
–, not performed; BCVA, best corrected visual acuity; CR, combined response; ELM, external limiting membrane; ERG, electroretinography; FAF, fundus autofluorescence; IS, inner 
segments; LE, left eye; mfERG, multifocal ERG; ONL, outer nuclear layer; OP, oscillatory potentials; OS, outer segments; PR, photopic response; RE, right eye; RPE, retinal pigment 
epithelium; SD-OCT, spectral domain optical coherence tomography; SR, scotopic response; VEP, visual evoked potentials.
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Strikingly, fundus exam and CFP were normal in all patients. 
These results are in line with previous histopathological 
studies in two patients with classic variant, reporting loss of 
the photoreceptor cells and the degeneration of outer nuclear 
and outer plexiform layers.7 14 Egan and colleagues studied 
electroretinographic responses in patients with NBIA without 
clearly differentiating between classical and atypical variants.5 
In their series, the majority of patients presented ERG abnor-
malities, ranging from mild to severe rod–cone dysfunction.5 
Retinal dysfunction in NBIA has been ascribed to iron overload 
and coenzyme A deficit .1 14 15 Iron is particularly important 
for the visual phototransduction cascade and in hereditary 
iron homeostasis disorders such as NBIA, retinal iron buildup 
leads to the production of toxic reactive oxygen species, thus 
contributing to retinal degeneration.15 Additionally, PKAN 
is an essential regulatory enzyme in the production of coen-
zyme A.1 PKAN mutations may lead to coenzyme A depletion, 
which in tissues with high coenzyme A consumption such as 
retina, may also contribute to the development of retinopathy 
in these patients.1 14 15 Overall, our data on visual function 
in patients with atypical NBIA indicate that retinal degener-
ation occurs both in classical and atypical variants of NBIA 
and not only in the former type as initially thought. More-
over, the use of more sensitive diagnostic testing (eg, ERG) is 
required in these patients for detecting retinal dysfunction at 
an earlier phase. There were no patients showing imaging and/
or structural evidence of optic atrophy, and three additional 
patients also demonstrated normal VEP. These data in atypical 
NBIA support the sparing of the optic nerve,5 in contrast with 
previous reports of optic atrophy in classical variant, probably 
secondary to retinal degeneration.1 2
Ocular motor data indicate that the atypical variant NBIA is 
associated with marked instability of ocular fixation. Frequent 
SWJ, but also pervasive SP, were found in the majority of patients. 
The underlying mechanism for pathological SWJ (ie, frequent, 
large and multidirectional) is still unclear, but their presence may 
reflect a dysfunctional inhibitory system (including basal ganglia 
and cerebellum), which is no longer suppressing unwanted 
saccades during ocular fixation.16 17 However, pervasive SP 
have been less frequently described in the literature and, to our 
knowledge, never before in patients with NBIA.16 The mecha-
nism underlying the generation of SP seems to be similar to that 
of SWJ.16 17 Future studies in a larger number of patients should 
explore their diagnostic potential in NBIA. Ocular pursuit was 
mildly impaired in a subset of patients, supporting the existence 
of widespread cortical/subcortical (and possibly brainstem and/
or cerebellar) dysfunction in NBIA.18 19 Apart from the presence 
of hypermetric saccades suggesting cerebellar dysfunction in one 
patient,12 saccades in our sample were generally spared. This 
contrasts with Egan et al’s3 5 findings in a younger NBIA group. 
Here the authors demonstrated that slow vertical saccades were 
frequently present, suggesting midbrain degeneration, although 
a differentiation between classical and atypical variants was not 
established. Therefore, brainstem saccade-generating centres 
may be spared in the atypical variant of NBIA. Both vertical and 
horizontal OKN responses were mildly impaired in two patients. 
Figure 2 (A) Patient 1 presenting SP (arrow) (2.4/seg;<3°), sometimes followed by SWJ (55/min;<5°). (B) Patient 3 demonstrating frequent SP 
(arrow) (1.2/seg; <2°). SP, saccadic pulses; SWJ, square wave jerks.
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Since the OKN system shares similar neural circuitry to the 
pursuit and vestibular systems, concomitant involvement of the 
latter circuitries in these patients might justify OKN decreased 
gain.20 Finally, VOR function, especially at low and interme-
diate frequencies (caloric and rotatory responses), was impaired 
in three out of seven patients. This is a novel clinical finding 
in patients with atypical NBIA and deserves further investiga-
tion. While to date, there has been no evidence for intrinsic 
involvement of the vestibular system in NBIA, cerebellar damage 
may play a role in VOR dysfunction.1 4 14 Indeed, cerebellum 
is known to modulate VOR responses, and a cerebellar lesion 
may promote changes in the VOR gain.21–23 Interestingly, histo-
pathological and functional evidence for cerebellar involvement 
in NBIA has been provided.24 25
Our study has limitations. The small number of patients 
included, clinically and genetically heterogeneous, prevented us 
from establishing putative genotype–phenotype correlations. Our 
transversal assessment also precluded any conclusion regarding 
the progression of the visual damage in atypical NBIA. Never-
theless, we were able to provide a comprehensive analysis of the 
afferent and efferent visual systems in the atypical form of NBIA.
In sum, similarly to the classical type, only a minority of 
patients with atypical NBIA showed structural evidence of reti-
nopathy, while they all demonstrated retinal functional changes. 
Optic nerve and saccade network however seem to be spared 
in the atypical form of the disease. Importantly, the presence of 
retinopathy and marked fixation instability, including the pres-
ence of pervasive saccadic pulses, in a young adult presenting 
with dystonia and cognitive decline should raise the suspicion 
for the atypical form of NBIA.
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Table 3 Ocular motor findings
Patient 
number Fixation
Smooth 
pursuit
(gain)
Saccades
(latency; average 
velocity; gain)
OKN
(gain) MVT HST
VHIT
(gain) Rotatory chair tests Caloric tests
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sec;<3°)
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V: 0.8
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V: 90%
LBN (SPV 4.8°/
sec)
Normal R: 1.20
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2 Frequent SWJ (0.8/
sec;<5°)
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H: 199 ms; 374°/
sec; 0.8
V: 221 ms; 333°/
sec; 0.9
H: 77%
V: 57%
RBN
(SPV 4.5°/sec)
Normal R: 1.10
L: 1.17
Symmetric responses LUW: 19%
3 Frequent SP* (1.2/
sec;<2°)
H: 0.8
V: 0.8
H: 205 ms; 560°/
sec; 1.1
V: 156 ms; 541°/
sec; 1.1
H: 108%
V: 104%
No nystagmus Normal R: 1.00
L: 1.10
Symmetric responses at 0.32 
and 0.64 Hz. Hyporeflexive 
responses at 0.16 Hz.
LUW: 13%
4 LBN (SPV: 2.2°/sec) H: 0.7
V: 0.9
– – RBN
(SPV 8.5°/sec)
Normal R: 0.93
L: 0.90
– –
5 Frequent SWJ (1.5/
sec,<5 °)
H: 0.8
V: 0.8
H: 237 ms: 444°/
sec; 0.9
V: 266 ms; 388 °/
sec; 0.8
H: 94%
V: 93%
No nystagmus Normal R: 1.05
L: 0.99
– RUW: 85%
6 Frequent SP (0.8/
sec;<1°)
H: 0.7
V: 0.7
H: 250 ms; 472°/
sec; 0.8
V: 286 ms; 529°/
sec; 0.8
H: 67%
V: 69%
RBN
(SPV 3.0°/sec)
Normal R: 0.96
L: 0.83
Hyporeflexive responses at 
0.16 and 0.32 Hz.
LUW: 34%
7† Normal H: 0.7
V: 0.7
– H: 101%
V: 110%
– – R: 1.11
L: 1.12
– –
*Both deep brain stimulation on and off.
†In terms of ocular motor assessment, vertical and horizontal pursuit was slightly decomposed, vertical and horizontal saccade speed and amplitude seemed normal at bedside, 
as well as horizontal head impulse.
–, not performed; H, horizontal; HST, head-shaking-induced nystagmus test; L, left; LBN, left beating nystagmus; LUW, left unilateral weakness; MVT, mastoid vibration-induced 
nystagmus test; OKN, optokinetic nystagmus; R, right; RBN, right beating nystagmus; RUW, right unilateral weakness; SP, saccadic pulses; SPV, slow-phase velocity; SWJ, square 
wave jerks; V, vertical; VHIT, video-horizontal head impulse test.
group.bmj.com on May 14, 2017 - Published by http://bjo.bmj.com/Downloaded from 
7Jesus-Ribeiro J, et al. Br J Ophthalmol 2017;0:1–7. doi:10.1136/bjophthalmol-2017-310181
Clinical science
(formerly Hallervorden-Spatz syndrome). Am J Ophthalmol  
2005;140:267–74.
 6 Dooling EC, Schoene WC, Richardson EP. Hallervorden-Spatz syndrome. Arch Neurol 
1974;30:70–83.
 7 Luckenbach MW, Green WR, Miller NR, et al. Ocular clinicopathologic correlation of 
Hallervorden-Spatz syndrome with acanthocytosis and pigmentary retinopathy. Am J 
Ophthalmol 1983;95:369–82.
 8 Hood DC, Bach M, Brigell M, et al. ISCEV standard for clinical multifocal 
electroretinography (mfERG) (2011 edition). Doc Ophthalmol  
2012;124:1–13.
 9 Marmor MF, Fulton AB, Holder GE, et al. ISCEV Standard for full-field clinical 
electroretinography (2008 update). Doc Ophthalmol 2009;118:69–77.
 10 Recommended Standards for Visual Evoked Potentials. American Clinical 
Neurophysiology Society 2008.
 11 Mariotti C, Alpini D, Fancellu R, et al. Spinocerebellar ataxia type 17 (SCA17): 
oculomotor phenotype and clinical characterization of 15 italian patients. J Neurol 
2007;254:1538–46.
 12 Wessel K, Moschner C, Wandinger KP, et al. Oculomotor testing in the differential 
diagnosis of degenerative ataxic disorders. Arch Neurol 1998;55:949.
 13 MacDougall HG, Weber KP, McGarvie LA, et al. The video head impulse test: 
diagnostic accuracy in peripheral vestibulopathy. Neurology 2009;73:1134–.
 14 Tripathi RC, Tripathi BJ, Bauserman SC, et al. Clinicopathologic correlation and 
pathogenesis of ocular and central nervous system manifestations in Hallervorden-
Spatz syndrome. Acta Neuropathol 1992;83:113–9.
 15 He X, Hahn P, Iacovelli J, et al. Iron homeostasis and toxicity in retinal degeneration. 
Prog Retin Eye Res 2007;26:649–73.
 16. Lemos J, Eggenberger E. Saccadic intrusions: review and update. Curr Opin Neurol 
2013;26:59–66.
 17 Zee DS, Robinson DA. A hypothetical explanation of saccadic oscillations. Ann Neurol 
1979;5:405–14.
 18. Pierrot-Deseilligny C, Gaymard B. Smooth pursuit disorders. Baillieres Clin Neurol 
1992;1:435–54.
 19. Pierrot-Deseilligny C. Saccade and smooth-pursuit impairment after cerebral 
hemispheric lesions. Eur Neurol 1994;34:121–34.
 20 Knapp CM, Proudlock FA, Gottlob I. OKN asymmetry in human subjects: a literature 
review. Strabismus 2013;21:37–49.
 21 Zee DS, Yamazaki A, Butler PH, et al. Effects of ablation of flocculus and 
paraflocculus of eye movements in primate. J Neurophysiol 1981;46:878–99.
 22 Waespe W, Cohen B, Raphan T. Role of the flocculus and paraflocculus in optokinetic 
nystagmus and visual-vestibular interactions: effects of lesions. Exp Brain Res 
1983;50:9–33.
 23 Cohen H, Cohen B, Raphan T, et al. Habituation and adaptation of the 
vestibuloocular reflex: a model of differential control by the vestibulocerebellum. Exp 
Brain Res 1992;90:526–38.
 24 Neumann M, Adler S, Schlüter O, et al. Alpha-synuclein accumulation in a case 
of neurodegeneration with brain iron accumulation type 1 (NBIA-1, formerly 
Hallervorden-Spatz syndrome) with widespread cortical and brainstem-type lewy 
bodies. Acta Neuropathol 2000;100:568–74.
 25 Szyszko TA, Dunn JT, O'Doherty MJ, et al. Role of (1)(8)F-FDG PET imaging in 
paediatric primary dystonia and dystonia arising from neurodegeneration with brain 
iron accumulation. Nucl Med Commun 2015;36:1–76.
group.bmj.com on May 14, 2017 - Published by http://bjo.bmj.com/Downloaded from 
iron accumulation type I
brainatypical form of neurodegeneration with 
Visual and ocular motor function in the
Januário
Matos, Aldina Reis, João Lemos, Miguel Castelo-Branco and Cristina 
Joana Jesus-Ribeiro, Cláudia Farinha, Margarida Amorim, Anabela
 published online May 9, 2017Br J Ophthalmol 
 1
http://bjo.bmj.com/content/early/2017/05/09/bjophthalmol-2017-31018
Updated information and services can be found at: 
These include:
References
 #BIBL1
http://bjo.bmj.com/content/early/2017/05/09/bjophthalmol-2017-31018
This article cites 24 articles, 1 of which you can access for free at: 
service
Email alerting
box at the top right corner of the online article. 
Receive free email alerts when new articles cite this article. Sign up in the
Notes
http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
http://journals.bmj.com/cgi/reprintform
To order reprints go to:
http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
group.bmj.com on May 14, 2017 - Published by http://bjo.bmj.com/Downloaded from 
